March 1, 2018
Novavax plans Phase 2 trial of NanoFlu vaccine in third quarter of 2018
NanoFlu vaccine was well tolerated over the three-week trial period, Novavax said Thursday, adding it now expects to begin a…
Pharmaceuticals, Biotechnology and Life Sciences
Tag: NnoFlu